Key result
High-power short-duration ablation linked to ~4-fold higher symptomatic pulmonary vein stenosis vs conventional ablation.
Why the study?
High-power short-duration AF catheter ablation is widely accepted, but the occurrence of symptomatic pulmonary vein stenosis according to the type of ablation had not been well assessed.
Cohort (n=4,333)
No
Answers are grounded in this paper and cite their sources.
May warrant caution with high-power short-duration ablation; leaves open need for randomized confirmation of stenosis risk.
Graphical Abstract Graphical abstract Computed tomography (CT) images of stenotic pulmonary vein before (A) and after atrial fibrillation catheter ablation (AFCA) (B). Kaplan–Meier curves for the cumulative incidence of pulmonary vein stenosis after AFCA. Top arrow of (A) pre-procedural right inferior pulmonary vein (RIPV), bottom arrow of (A) pre-procedural three-dimensional (3D) reconstructed image of RIPV, and arrows of (B) stenotic RIPV after AFCA. AF, atrial fibrillation; ConvP-AFCA, conventional power atrial fibrillation catheter ablation; HPSD, high-power short duration.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2023) conducted a cohort in Atrial fibrillation undergoing catheter ablation (n=4,333). High-power short-duration atrial fibrillation catheter ablation (HPSD-AFCA) vs. Conventional power atrial fibrillation catheter ablation (ConvP-AFCA: 30-35 W anterior, 25-30 W posterior) and cryoablation was evaluated on Symptomatic pulmonary vein stenosis (PVS) (p=0.001). High-power short-duration radiofrequency ablation was associated with a higher incidence of symptomatic pulmonary vein stenosis than conventional power ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: